K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Gary Gordon
also known as G B Gordon, G GORDON, G Gordon
Ametek (United States) · University of Maryland, Baltimore · Dartmouth–Hitchcock Medical Center · BC Cancer Agency
About this author
Works
187
Cited by
12,052
h-index
42
i10
81
Top papers
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Gideon Steinbach, Patrick M. Lynch, Robin Phillips, et al.
·
2000
·
New England Journal of Medicine
↗ 2,523
OA
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber, et al.
·
2006
·
New England Journal of Medicine
↗ 1,036
OA
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
·
2016
·
The Lancet Oncology
↗ 793
OA
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Matthew S. Davids, Andrew W. Roberts, John F. Seymour, et al.
·
2017
·
Journal of Clinical Oncology
↗ 747
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
Susan M. Fischer, Herng-Hsang Lo, Gary Gordon, et al.
·
1999
·
Molecular Carcinogenesis
↗ 404
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
Joyce O’Shaughnessy, Gary J. Kelloff, Gary Gordon, et al.
·
2002
·
PubMed
↗ 383
OA
Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
Shivaani Kummar, Robert J. Kinders, Martin Gutierrez, et al.
·
2009
·
Journal of Clinical Oncology
↗ 329
OA
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
John F. Seymour, Shuo Ma, Danielle M. Brander, et al.
·
2017
·
The Lancet Oncology
↗ 325
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
·
2018
·
Journal of Clinical Oncology
↗ 310
OA
Distinguishing right from left colon by the pattern of gene expression.
O K Glebov, Luz M. Rodriguez, Kenneth Nakahara, et al.
·
2003
·
PubMed
↗ 284
Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.
Gary Gordon, David E. Bush, Harlan F. Weisman
·
1988
·
Journal of Clinical Investigation
↗ 240
OA
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
Craig A. Elmets, Jaye L. Viner, Alice P. Pentland, et al.
·
2010
·
JNCI Journal of the National Cancer Institute
↗ 240
OA
Books
Interior Lighting for Designers
2007
·
Wiley
Interior lighting for designers
1995
·
J. Wiley